Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 28, 2019Journal of Allergy and Clinical ImmunologyOpen Access

Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

Emma Guttman‐Yassky
Emma Guttman‐YasskyUniversity of CopenhagenDTDiamant ThaçiInstitute for Integrative and Experimental GenomicsAPAileen L. PanganMerck & Co., Inc., Rahway, NJ, USA (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Guttman‐Yassky et al. (2019) studied this question.

synapsesocial.com/papers/69de7dac681d8c8a46e93fc4https://doi.org/10.1016/j.jaci.2019.11.025
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diagnostic Features of Atopic Dermatitis1980 · 5,131 citations
  2. 2Selective JAK inhibitors in development for rheumatoid arthritis2014 · 160 citations
  3. 3Severity Scoring of Atopic Dermatitis: The SCORAD Index2009 · 2,323 citations
  4. 4Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study2017 · 832 citations